Tenax Therapeutics stock forecast
Want to see TENX full AI Analyst Report?
Tenax Therapeutics (TENX) Stock Forecast & Price Target
TENX Analyst Ratings
TENX Stock 12 Month Forecast
Average Price Target
$12.40▲(633.73% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Angela Qian | Canaccord Genuity | $4 | buy | 136.69%Upside | Reiterated | 11/06/26 | ||
| Jonathan Aschoff | Roth MKM | $5 | buy | 195.86%Upside | Reiterated | 11/06/26 | ||
| David Risinger | Leerink Partners | $4 | buy | 136.69%Upside | Reiterated | 10/09/26 | ||
| Yasmeen Rahimi | Piper Sandler | $14 | buy | 728.40%Upside | Reiterated | 09/15/26 | ||
| Olivia Brayer | Cantor Fitzgerald | $35 | buy | 1971.01%Upside | Reiterated | 09/09/26 | ||
| Seamus Fernandez | Guggenheim | ― | hold | ― | Downgraded | 08/31/26 | ||
| Matt Phipps | William Blair | ― | hold | ― | Reiterated | 08/31/26 | ||
| Gautam Chukka | Chardan Capital | $27→$5 | hold | 195.86%Upside | Downgraded | 08/11/26 | ||
| Gavin Clark-Gartner | Evercore ISI | $39→$5 | hold | 195.86%Upside | Downgraded | 08/10/26 | ||
| Gaurav Maini | LifeSci Capital | $35→$5 | buy | 195.86%Upside | Reiterated | 08/10/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Angela QianCanaccord Genuity | BuyReiterated$4 | 11/06/26 | 136.69%Upside | ||
| Jonathan AschoffRoth MKM | BuyReiterated$5 | 11/06/26 | 195.86%Upside | ||
| David RisingerLeerink Partners | BuyReiterated$4 | 10/09/26 | 136.69%Upside | ||
| Yasmeen RahimiPiper Sandler | BuyReiterated$14 | 09/15/26 | 728.40%Upside | ||
| Olivia BrayerCantor Fitzgerald | BuyReiterated$35 | 09/09/26 | 1971.01%Upside | ||
| Seamus FernandezGuggenheim | HoldDowngraded | 08/31/26 | ― | ||
| Matt PhippsWilliam Blair | HoldReiterated | 08/31/26 | ― | ||
| Gautam ChukkaChardan Capital | HoldDowngraded$27→$5 | 08/11/26 | 195.86%Upside | ||
| Gavin Clark-GartnerEvercore ISI | HoldDowngraded$39→$5 | 08/10/26 | 195.86%Upside | ||
| Gaurav MainiLifeSci Capital | BuyReiterated$35→$5 | 08/10/26 | 195.86%Upside |
Best Analysts Covering Tenax Therapeutics
Copying David Risinger's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +15.90% per trade.
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +21.71% per trade.
Copying Jonathan Aschoff's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -26.74% per trade.
TENX Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 15 | 21 | 18 | 13 | 5 |
| Buy | 4 | 3 | 3 | 0 | 0 |
| Hold | 0 | 5 | 5 | 5 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 19 | 29 | 26 | 18 | 5 |
In the current month, TENX has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TENX average Analyst price target in the past 3 months is 12.40.
TENX Financial Forecast
TENX Earnings Forecast
Next quarter’s earnings estimate for TENX is -$0.36 with a range of -$0.46 to -$0.32. The previous quarter’s EPS was -$0.31. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
TENX Sales Forecast
Next quarter’s sales forecast for TENX is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
